mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.1 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |